Ambulatory Surgery Center EBITDA Multiples: 2026 Report
Ambulatory surgery centers (ASCs) have become one of the most attractive segments in healthcare services M&A. As surgical procedures continue shifting from hospitals to outpatient settings, ASCs provide a lower-cost, efficient alternative for patients and payers. Advances in minimally invasive techniques have expanded the number of procedures that can safely be performed in these facilities, accelerating the move toward outpatient care (Scope Research, 2025).
Most ASC transactions are valued using a multiple of adjusted EBITDA, which serves as a proxy for operating profitability and allows investors to compare centers across markets and specialties. Because EBITDA approximates operating cash flow and removes non-cash accounting factors, buyers use it to evaluate a center’s ability to generate stable earnings and support future growth (VMG Health, 2023).
This report summarizes the current market ranges for ASC EBITDA multiples and the factors that typically push valuations higher or lower in a transaction.
What you’ll learn in this article:
Typical EBITDA multiples for ambulatory surgery centers in 2026
How specialty mix and physician alignment influence valuation
Why payer mix and out-of-network revenue affect multiples
The difference between minority and controlling-interest pricing
Operational factors that move ASC valuations up or down
ASC Valuation Basics: The Role of EBITDA
Healthcare investors generally value surgery centers using enterprise value (EV) relative to EBITDA:
Enterprise Value ≈ Adjusted EBITDA × Market Multiple
EBITDA approximates the cash flow available to owners and investors. Because it excludes capital structure decisions and non-cash accounting expenses, EBITDA allows buyers to compare facilities with different financing structures and equipment investments.
However, buyers rarely apply a simple multiple to historical earnings without further analysis. In practice, investors normalize EBITDA to account for one-time expenses, related-party arrangements, or unusual revenue patterns. These adjustments allow buyers to evaluate the center’s sustainable earnings potential before determining an implied valuation multiple (VMG Health, 2023).
Typical ASC EBITDA Multiples (2026 Market Benchmarks)
The ASC market exhibits a wide range of valuation outcomes depending on ownership structure, specialty mix, and growth potential. Recent transaction data suggests the following typical EBITDA multiple ranges:
| ASC Type | Typical EBITDA Multiple | Key Drivers |
|---|---|---|
| Non-controlling physician interests | ~3×–6× | Minority ownership discount, limited control |
| Single-specialty ASC | ~5×–8× | Specialty concentration, surgeon dependency |
| Multi-specialty ASC | ~6×–10× | diversified procedures and physician-based |
| Regional ASC operators/management companies | ~11×–17× | multi-site scale and infrastructure |
Source: Scope Research
These ranges reflect the variation between minority investments, individual surgery centers, and scaled operators that own or manage multiple facilities. Larger management companies with strong growth platforms can command significantly higher multiples due to their ability to replicate partnerships with physicians across multiple markets.
FOCUS has experienced higher multiples for single-specialty surgery centers when sold alongside the associated medical practice to a specialty-focused private equity buyer. In those cases, EBITDA multiples can reflect the size and value of the combined “package”, rather than the ASC alone.
Minority vs. Controlling Interest Transactions
Ownership structure plays a significant role in ASC valuation.
In many transactions, national ASC operators or hospital systems acquire majority ownership stakes while physicians retain minority ownership interests in the center. These structures allow physicians to remain financially aligned with the facility while leveraging the operational resources of a larger organization (McGuireWoods, ASC Transactions Overview).
Minority interests typically trade at lower multiples because they lack governance control and management authority. Physician investors purchasing minority units may pay approximately 3×–5× EBITDA, while controlling buyers acquiring majority stakes may pay 6×–8× EBITDA or higher, depending on the quality of the center (McGuireWoods, ASC Transactions Overview).
The difference in valuation reflects both governance rights and economic participation. Controlling buyers often receive management agreements and operational authority, which can increase the total economic value of the investment.
Operational Factors That Influence ASC Multiples
ASC valuation multiples vary significantly depending on the perceived stability and growth potential of the facility.
Several operational characteristics consistently influence investor pricing.
Specialty and Case Mix
The mix of surgical specialties performed within a center can meaningfully affect valuation. Multi-specialty facilities generally command higher multiples because they diversify procedure revenue and reduce reliance on a single physician group or surgical discipline (Scope Research, 2025).
Single-specialty centers can still achieve strong valuations when the specialty is particularly profitable or in high demand, but they carry higher concentration risk if surgical volume depends heavily on a limited number of surgeons.
Physician Alignment
Investor confidence often depends on the stability of physician relationships within the center. Facilities that rely heavily on one or two surgeons for case volume face higher risk, which can reduce valuation multiples (McGuireWoods, ASC Transactions Overview).
Conversely, centers with a broad physician ownership base and stable referral patterns typically achieve stronger pricing in transactions.
Payer Mix
Payer composition also affects valuation.
High levels of out-of-network revenue can introduce uncertainty about the durability of reimbursement rates. If regulatory changes or payer negotiations reduce reimbursement levels, profit margins could decline significantly. As a result, investors may discount valuations for centers that depend heavily on out-of-network billing models (Scope Research, 2025).
Growth Capacity
Buyers also evaluate whether the center has the capacity to expand surgical volume.
Facilities that have additional operating room capacity, the ability to recruit new surgeons, or opportunities to expand into additional specialties may command higher valuation multiples due to their future growth potential (Scope Research, 2025).
Market Structure and Buyer Landscape
ASC acquisitions are pursued by a diverse group of buyers, including hospital systems, national ASC management companies, and private equity-backed operators (who are often focused in a single specialty).
Hospitals frequently acquire ownership stakes in local ASCs to strengthen relationships with referring physicians and maintain surgical volume within their networks. These partnerships may involve majority or minority ownership depending on the strategic objectives of the parties involved (McGuireWoods, ASC Transactions Overview).
Private equity-backed operators and national ASC companies, by contrast, typically pursue multi-center strategies aimed at building regional or national platforms. These investors often seek facilities that can serve as anchors for future physician partnerships and geographic expansion. PE-backed operators in the physician practice management space often acquire single-specialty ASCs along with an associated physician group. These transactions can result in premium pricing for a single-specialty ASC.
Because the ASC sector remains fragmented, consolidation opportunities continue to attract financial sponsors seeking scalable healthcare assets (Scope Research, 2025).
What Pushes ASC Valuations Higher or Lower
| Premium Drivers | Valuation Discounts |
|---|---|
| Multi-specialty case mix | Single-specialty concentration |
| Diverse physician ownership | Dependence on a few surgeons |
| Strong commercial payer mix | Heavy out-of-network revenue |
| Demonstrated growth potential | Limited expansion capacity |
| Favorable local market dynamics | High competition from hospitals or other ASCs |
Investors ultimately evaluate both current profitability and future growth potential when determining the final transaction value. Two centers with similar EBITDA levels can receive materially different valuations depending on the stability and scalability of their business models (VMG Health, 2023).
Putting It Together: How ASC Valuations Are Determined
ASC transactions are often discussed in terms of headline EBITDA multiples, but the final valuation is usually determined through a deeper financial analysis.
Investors may conduct detailed cash flow modeling to project future earnings and evaluate risk factors such as payer mix, physician alignment, staffing costs, and capital expenditure requirements. The resulting valuation estimate is then compared to market multiples observed in similar transactions to confirm that the implied pricing falls within a reasonable range (VMG Health, 2023).
Understanding these market benchmarks can help ASC owners evaluate potential transaction opportunities and position their centers for stronger valuation outcomes.
Learn More
FOCUS Investment Banking specializes in maximizing transaction value for ambulatory surgery center owners through our proven quarterback approach to M&A advisory.
If you’d like to learn more about our healthcare investment banking services, you can reach out here.
All valuation ranges are presented for educational purposes only and are not a guarantee of any outcome.
